Psychostimulants as antidepressants: Their nuanced role?
1Scientia Professor Psychiatry, Discipline of Psychiatry and Mental Health, School of Clinical Medicine, The University of New South Wales, Australia.
The Australian and New Zealand Journal of Psychiatry
|March 3, 2022
Summary
Psychostimulants, though rarely used as antidepressants, show effectiveness for major depression. This study explores their specific benefits for treatment-resistant melancholic depression, noting manageable side effects.
Area of Science:
- Psychiatry and Pharmacology
- Neuroscience
Background:
- Psychostimulants were early antidepressants but are now rarely prescribed due to concerns about effectiveness, side effects, tolerance, dependency, and abuse.
- Recent meta-analyses suggest psychostimulants may be effective for major depression.
- Their specific role in treating treatment-resistant melancholic depression remains under-evaluated.
Purpose of the Study:
- To evaluate the nuanced role of psychostimulants in treating treatment-resistant melancholic depression (both unipolar and bipolar).
- To present a case for the benefits of psychostimulants in a specific patient population.
Main Methods:
- Clinical experience over a decade of prescribing psychostimulants for treatment-resistant depression.
- Review of existing meta-analyses on psychostimulant efficacy for major depression.
Main Results:
- Psychostimulants demonstrate effectiveness as antidepressants for major depression.
- Evidence suggests potential benefits for a distinct percentage of patients with treatment-resistant melancholic depression.
- Observed side effects are relatively few and manageable.
Conclusions:
- Psychostimulants warrant consideration for treating specific cases of treatment-resistant melancholic depression.
- Their established efficacy in major depression supports further investigation in specialized populations.
- Concerns regarding side effects and abuse may be overstated in the context of carefully selected patients.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
400
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
400
01:25Antidepressant Drugs: Overview
852
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
852
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
694
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
694
01:28Drug Therapy
110
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
110
01:22CNS Stimulants: Psychedelic Agents
279
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
279
01:25Adrenergic Agonists: Indirect-Acting Agents
2.0K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.0K